Etomidate Injection is the generic version of Hospira’s Amidate Injection, which is an intravenous general anesthesia.
The newly-approved drug has begun shipping in the United States. Sales for the last 12 months of Etomidate Injection, ending in March, were $6.58 million.
More Articles on Anesthesia:
Colorado Society of Anesthesiologists ‘Dismayed’ at CRNA Ruling
Dr. Benjamin Rubin Joins Fox Chase Anesthesiology
FDA Issues Class 1 Recall for Maquet Anesthesia System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
